Home › Employers › Emergent BioSolutions Inc.
Emergent BioSolutions Inc.: H-1B salaries and sponsorship
Emergent BioSolutions Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $169,978.
Does Emergent BioSolutions Inc. sponsor H-1B visas?
Emergent BioSolutions Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Nov 1, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Sr. Business Analyst, FTF | 1 | $169,978 |
| Specialist, Quality Assurance | 1 | $117,915 |
| Director, Corporate Development | 1 | $225,014 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 2 | $143,946 |
| FY2025 | 1 | $225,014 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Director, Corporate Development | $225,014 Level II | Bedford, MA | Nov 1, 2024 | Nov 25, 2024 | Certified |
| Specialist, Quality Assurance | $117,915 Level II | Gaithersburg, MD | Apr 16, 2024 | May 1, 2024 | Certified, then withdrawn |
| Sr. Business Analyst, FTF | $169,978 Level III | Gaithersburg, MD | Mar 6, 2024 | Sep 5, 2024 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).